Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-23

FDA Approved: SUMATRIPTAN — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sumatriptan from Bionpharma Inc., updating the approval status of this generic migraine medication under the ANDA pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)